OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

C-peptide: New findings and therapeutic possibilities
John Wahren, Charlotte Larsson
Diabetes Research and Clinical Practice (2015) Vol. 107, Iss. 3, pp. 309-319
Closed Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Peripheral Neuropathy in Mouse Models of Diabetes
Corinne G. Jolivalt, Katie Frizzi, Lucie S. Guernsey, et al.
Current Protocols in Mouse Biology (2016) Vol. 6, Iss. 3, pp. 223-255
Open Access | Times Cited: 112

Na,K-ATPase regulation in skeletal muscle
Sergej Pirkmajer, Alexander Chibalin
AJP Endocrinology and Metabolism (2016) Vol. 311, Iss. 1, pp. E1-E31
Open Access | Times Cited: 104

Oral Delivery of Protein Drugs Bioencapsulated in Plant Cells
Kwang‐Chul Kwon, Henry Daniell
Molecular Therapy (2016) Vol. 24, Iss. 8, pp. 1342-1350
Open Access | Times Cited: 87

Aldose reductase, ocular diabetic complications and the development of topical Kinostat®
Peter F. Kador, Milton Wyman, Peter J. Oates
Progress in Retinal and Eye Research (2016) Vol. 54, pp. 1-29
Open Access | Times Cited: 72

Specific and Non-Specific Biomarkers in Neuroendocrine Gastroenteropancreatic Tumors
Andrea Sansone, Rosa Lauretta, Sebastiano Vottari, et al.
Cancers (2019) Vol. 11, Iss. 8, pp. 1113-1113
Open Access | Times Cited: 55

Study on risk factors of diabetic peripheral neuropathy and establishment of a prediction model by machine learning
Xiaoyang Lian, Juanzhi Qi, Mengqian Yuan, et al.
BMC Medical Informatics and Decision Making (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 19

The role of C-peptide in diabetes and its complications: an updated review
Jintao Chen, Yajing Huang, Chuanfeng Liu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 15

The effect of C-peptide on diabetic nephropathy: A review of molecular mechanisms
Habib Yaribeygi, Mina Maleki, Thozhukat Sathyapalan, et al.
Life Sciences (2019) Vol. 237, pp. 116950-116950
Open Access | Times Cited: 38

C-Peptide as a Therapy for Type 1 Diabetes Mellitus
Rachel L. Washburn, Karl Mueller, Gurvinder Kaur, et al.
Biomedicines (2021) Vol. 9, Iss. 3, pp. 270-270
Open Access | Times Cited: 32

Residual C-peptide secretion is associated with better CGM-metrics in adults with short-lasting type 1 diabetes
Rocco Amendolara, Simona Zampetti, Antonio De Siena, et al.
Diabetes Research and Clinical Practice (2025), pp. 112006-112006
Closed Access

Diabetic neuropathy: cutting-edge research and future directions
Yang Yang, Bing Zhao, Yuanzhe Wang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access

Association of increased levels of MCP-1 and cathepsin-D in young onset type 2 diabetes patients (T2DM-Y) with severity of diabetic retinopathy
S. Siva Ram Reddy, Anandakumar Amutha, Ramachandran Rajalakshmi, et al.
Journal of Diabetes and its Complications (2017) Vol. 31, Iss. 5, pp. 804-809
Closed Access | Times Cited: 35

Emerging drugs for diabetic peripheral neuropathy and neuropathic pain
Νικόλαος Παπάνας, Dan Ziegler
Expert Opinion on Emerging Drugs (2016) Vol. 21, Iss. 4, pp. 393-407
Closed Access | Times Cited: 33

Pancreatic Blood Flow with Special Emphasis on Blood Perfusion of the Islets of Langerhans
Leif Jansson, Per‐Ola Carlsson
Comprehensive physiology (2019), pp. 799-837
Closed Access | Times Cited: 33

Biomarkers in metabolic syndrome
Young Hye Cho, Youngin Lee, Jung In Choi, et al.
Advances in clinical chemistry (2022), pp. 101-156
Closed Access | Times Cited: 17

Therapeutic effect of ultra-long-lasting human C-peptide delivery against hyperglycemia-induced neovascularization in diabetic retinopathy
Chan‐Hee Moon, Ah-Jun Lee, Hye‐Yoon Jeon, et al.
Theranostics (2023) Vol. 13, Iss. 8, pp. 2424-2438
Open Access | Times Cited: 10

The Physiology of Proinsulin C-Peptide: Unanswered Questions and a Proposed Model
Gina L. C. Yosten, Grant R. Kolar
Physiology (2015) Vol. 30, Iss. 4, pp. 327-332
Closed Access | Times Cited: 31

Growth factors and hormones pro‐peptides: the unexpected adventures of the BDNF prodomain
Juan Pablo Zanin, Nicolás Unsain, Agustín Anastasía
Journal of Neurochemistry (2017) Vol. 141, Iss. 3, pp. 330-340
Open Access | Times Cited: 31

C‐peptide antioxidant adaptive pathways in β cells and diabetes
Patrizia Luppi, Peter Drain
Journal of Internal Medicine (2016) Vol. 281, Iss. 1, pp. 7-24
Open Access | Times Cited: 30

Targeting orphan G protein‐coupled receptors for the treatment of diabetes and its complications: C‐peptide and GPR146
Grant R. Kolar, Stephen Grote, Gina L. C. Yosten
Journal of Internal Medicine (2016) Vol. 281, Iss. 1, pp. 25-40
Open Access | Times Cited: 28

Faba bean protein flours added to pasta reduce post-ingestion glycaemia, and increase satiety, protein content and quality
Catherine Chan, Hrvoje Fabek, Rebecca C. Mollard, et al.
Food & Function (2019) Vol. 10, Iss. 11, pp. 7476-7488
Closed Access | Times Cited: 26

C-peptide is independent associated with diabetic peripheral neuropathy: a community-based study
Xiaona Qiao, Hangping Zheng, Shuo Zhang, et al.
Diabetology & Metabolic Syndrome (2017) Vol. 9, Iss. 1
Open Access | Times Cited: 27

Page 1 - Next Page

Scroll to top